|
PROSTATE DIAGNOSTICS AND THERAPEUTICS |
|
|
PHILLIP KATELARIS
Urological Surgeon
|
Transrectal ultrasound with Prostate biopsy
Prostate MRI Nerve sparing Radical Prostatectomy High Dose Rate Brachytherapy Iodine Seed Brachytherapy High Intensity Focused Ultrasound BPH Management Urodynamics Prostate Laser Surgery |
Prostate Diagnostics and Therapeutics
Report by Dr Phillip M. Katelaris, Urological Surgeon, Sydney Adventist Hospital
Welcome to prostatecancer.com.au. The aim of his website is to inform about matters concerning prostate cancer screening, detection and treatment.
It is important that prostate cancer treatments are individualized to the individual patients age, longevity and medical morbidities. Tumour characteristics such as stage, grade and pre-biopsy PSA levels need also to be taken into account. It is necessary to offer a comprehensive prostate cancer service including radical prostatectomy, conformal radiotherapy, seed brachytherapy and high dose rate brachytherapy. It is also important to offer appropriate prostate cancer support networks and humane palliative care for patients with terminal prostate cancer. Dr. Katelaris' aim is to offer the above to patients in a way that is appropriate and comprehensible to patients and their families. Dr. Katelaris incorporates new technologies on their clinical merits and not simply because they are available, touted in the media, or because they have particular marketing value.
The following decision making analysis that is used in assessing each individual patients suitability for various treatments gives structure to the consultation and comprehensively incorporates all appropriate treatment options.
Prostate cancer is a curable disease. The mortality from prostate cancer has diminished by 25% during the last decade throughout the western world. Early detection and appropriate intervention is the key to this reduction in mortality.
Yours sincerely,
P.M. KATELARIS
It is important that prostate cancer treatments are individualized to the individual patients age, longevity and medical morbidities. Tumour characteristics such as stage, grade and pre-biopsy PSA levels need also to be taken into account. It is necessary to offer a comprehensive prostate cancer service including radical prostatectomy, conformal radiotherapy, seed brachytherapy and high dose rate brachytherapy. It is also important to offer appropriate prostate cancer support networks and humane palliative care for patients with terminal prostate cancer. Dr. Katelaris' aim is to offer the above to patients in a way that is appropriate and comprehensible to patients and their families. Dr. Katelaris incorporates new technologies on their clinical merits and not simply because they are available, touted in the media, or because they have particular marketing value.
The following decision making analysis that is used in assessing each individual patients suitability for various treatments gives structure to the consultation and comprehensively incorporates all appropriate treatment options.
Prostate cancer is a curable disease. The mortality from prostate cancer has diminished by 25% during the last decade throughout the western world. Early detection and appropriate intervention is the key to this reduction in mortality.
Yours sincerely,
P.M. KATELARIS
Disclaimer: This page may contain images unsuitable for viewing by young children
